Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion ; volume:8 ; number:1 ; day:06 ; month:10 ; year:2008 ; pages:1-8 ; date:12.2008
BMC cancer ; 8, Heft 1 (06.10.2008), 1-8, 12.2008
- Urheber
-
Okumura, Yasuhiro
- Beteiligte Personen und Organisationen
-
Yamamoto, Yutaka
Zhang, Zhenhuan
Toyama, Tatsuya
Kawasoe, Teru
Ibusuki, Mutsuko
Honda, Yumi
Iyama, Ken-ichi
Yamashita, Hiroko
Iwase, Hirotaka
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-8-287
- URN
-
urn:nbn:de:1111-2016030345665
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Okumura, Yasuhiro
- Yamamoto, Yutaka
- Zhang, Zhenhuan
- Toyama, Tatsuya
- Kawasoe, Teru
- Ibusuki, Mutsuko
- Honda, Yumi
- Iyama, Ken-ichi
- Yamashita, Hiroko
- Iwase, Hirotaka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Potential biomarkers of ductal carcinoma in situ progression
Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma
Features of ductal carcinoma in situ ultrasound images
Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
Status of Intraductal Therapy for Ductal Carcinoma in Situ
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
AI analytics can be used as imaging biomarkers for predicting invasive upgrade of ductal carcinoma in situ
Genetic predisposition to ductal carcinoma in situ of the breast
Classification of ductal carcinoma in situ by gene expression profiling
Genetic predisposition to ductal carcinoma in situ of the breast
Potential biomarkers of ductal carcinoma in situ progression
Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma
Features of ductal carcinoma in situ ultrasound images
Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
Status of Intraductal Therapy for Ductal Carcinoma in Situ
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
AI analytics can be used as imaging biomarkers for predicting invasive upgrade of ductal carcinoma in situ
Genetic predisposition to ductal carcinoma in situ of the breast
Classification of ductal carcinoma in situ by gene expression profiling
Genetic predisposition to ductal carcinoma in situ of the breast
Potential biomarkers of ductal carcinoma in situ progression
Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma
Features of ductal carcinoma in situ ultrasound images
Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
Status of Intraductal Therapy for Ductal Carcinoma in Situ
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
AI analytics can be used as imaging biomarkers for predicting invasive upgrade of ductal carcinoma in situ
Genetic predisposition to ductal carcinoma in situ of the breast
Classification of ductal carcinoma in situ by gene expression profiling